title: The development of sarcoidosis on antitumour necrosis factor therapy: a paradox.
authors.forename: A E
authors.initials: AE
authors.lastname: Pink
authors.forename: A
authors.initials: A
authors.lastname: Fonia
authors.forename: C H
authors.initials: CH
authors.lastname: Smith
authors.forename: J N W N
authors.initials: JN
authors.lastname: Barker
mesh_terms: D002908:Chronic Disease; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept